Rephonic
Artwork for The Readout Loud

The Readout Loud

STAT
Vertex Pharmaceuticals
FDA
Biotechnology
Venture Capital
CRISPR
Gilead Sciences
Rick Gonzalez
Obesity Treatments
Opioid Addiction
Sanofi
Clinical Trials
Abbvie
Pfizer
Aduhelm
Drug Development
Biotech Financing
Eli Lilly
Oncology
Car-T
Casgevi

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

PublishesWeeklyEpisodes378Founded8 years ago
Number of ListenersCategory
Business

Listen to this Podcast

Artwork for The Readout Loud

Latest Episodes

On this week’s episode of “The Readout LOUD”: an interview with veteran biotech executive and company founder Clive Meanwell. Pfizer recently acquired one of Meanwell’s companies, the obesity drug developer Metsera, for just under $5 billion.

Meanwe... more

Where did former vaccine regulator Peter Marks find a new job? How did a math error cost AstraZeneca a rare disease candidate? And is biotech back?

We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We brin... more

How will we look back on Emma Walmsley's tenure as GSK's CEO? Why did one of the FDA's top drug officials call out an obscure lupus drug on LinkedIn? And will we ever stop talking about the pharma patent cliff?

Adam is out this week, so Allison and E... more

We bring on UniQure CEO Matt Kapusta to discuss the company's announcement this week that its one-time treatment for Huntington’s disease significantly slowed down the neurological condition in a key study.

We also chat about the Trump's administrat... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more
Tradeoffs
TradeoffsTradeoffs

Recent Guests

Jared Holz
Healthcare Strategist at Mizuho
Mizuho
Episode: 373: Party in biotech land and AstraZeneca’s miscalculation
Dr. Dietmar Berger
Chief Medical Officer at Gilead Sciences
Gilead Sciences
Episode: 373: Party in biotech land and AstraZeneca’s miscalculation
Stacie Dusetzina
Health policy researcher
Vanderbilt University Medical Center
Episode: 372: A pharma C-suite shakeup and Trump's deal with Pfizer
Matt Kapusta
CEO of UniQure
UniQure
Episode: 371: A gene therapy success in Huntington's and Trump's autism announcement
Ari Ne'eman
Assistant professor of health policy and management at Harvard School of Public Health, former executive director of the Autistic Self Advocacy Network
Harvard School of Public Health
Episode: 371: A gene therapy success in Huntington's and Trump's autism announcement
Drew Joseph
Colleague reporting from London on UK life sciences
STAT
Episode: 370: Pharma sours on the U.K., plus biotech M&A's quiet roll
Mike Rea
Pharma consultant and head of the UK pharma consultancy, Idea Pharma, focusing on R&D productivity and drug development.
Idea Pharma
Episode: 369: Trump, Chinese biotech, and an industry career reshaped by illness
Chelsea Cirruzzo
STAT DC correspondent with insights on CDC developments
STAT
Episode: 367: The ouster of CDC's director, biotech venture firm rankings
Marissa Russo
STAT fellow and PhD candidate at the Mayo Clinic studying glioblastoma
Mayo Clinic
Episode: 365: Vinay Prasad’s return, animal testing alternatives, and mRNA upended

Hosts

Allison DeAngelis
Co-host providing insights on biotech news with an engaging style and a background in health reporting.
Adam Feuerstein
Co-host known for in-depth analyses on pharmaceutical and biotech topics with a journalistic lens.
Elaine Chen
Co-host with a focus on articulate discussions related to biotech and public health reporting, enhancing audience engagement.

Reviews

4.7 out of 5 stars from 557 ratings
  • Please reboot the old quality bar

    This podcast was a gold mine a few years back. Really miss that run you had. Adam is good but even he was better back when surrounded with higher caliber cohosts.

    Apple Podcasts
    3
    freedomtochoose
    United Statesa month ago
  • Way Too Political

    Like others have mentioned, this podcast has become way too political in how it covers this sector. Please cover the content with a little bit more neutrality, because it erodes the credibility of the hosts.

    Apple Podcasts
    2
    Kitten Kitten Star
    United States2 months ago
  • Your bias is showing

    Disappointing that your reporting of the DHHS staff cuts (and the new administration as a whole) is so one-sided. How about trying a neutral approach? Consider that some of your listeners have common sense.

    Apple Podcasts
    1
    bennoanddixie
    United States7 months ago
  • The best podcast out there

    This podcast will blow your mind, five stars

    Apple Podcasts
    5
    MilesMcKinley
    United States8 months ago
  • Great podcast

    It helps me catch up on the biotech news every week! Very informative.

    Apple Podcasts
    5
    HB4000
    United States8 months ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Hosts have a good grasp of the subject matter, although occasional critiques arise regarding their presentation style.
Informative and engaging discussions on biotech news, though some listeners wish for more neutrality in coverage.
There are mixed feelings about the hosts' biases, with some appreciating the thorough analysis while others seek a more balanced approach.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#81
Indonesia/Business
Apple Podcasts
#133
South Korea/Business
Apple Podcasts
#170
Ukraine/Business

Talking Points

Recent interactions between the hosts and their guests.

372: A pharma C-suite shakeup and Trump's deal with Pfizer
Q: Why do you think they focused on Medicaid and what impact, if any, do you think this agreement will have on Medicaid?
They focused on Medicaid likely due to the president's goals for companies, and for Pfizer, it felt like an easier concession to provide with minimal effect on their bottom line.
372: A pharma C-suite shakeup and Trump's deal with Pfizer
Q: What kind of impact will cutting out these middlemen have on the amount that patients pay out of pocket?
The effect of the direct to consumer sales will be fairly minimal as far as who actually benefits from using that type of system. It's more complicated than it appears due to the integration of pharmacy benefits managers and insurance plans.
372: A pharma C-suite shakeup and Trump's deal with Pfizer
Q: What stood out to you about how this deal came together and what kind of strategies that the president employed?
One of the things that has been somewhat effective here is the threat of substantial financial harm and uncertainty for the industry. The tariffs were a real threat that the industry has been able to see.
372: A pharma C-suite shakeup and Trump's deal with Pfizer
Q: Stacie, drug prices have been a rallying cry for the last few administrations. From a policy perspective, what cards does the government have to play and why has it been so difficult to move the needle on drug prices?
The government can do quite a lot, but actually we need cooperation within the government and congressional action to do the most to affect drug prices. Generally, we've seen less collaboration to really move the needle, although there have been some transformative policies pushed through.
370: Pharma sours on the U.K., plus biotech M&A's quiet roll
Q: What are the pharmaceutical industry's complaints about the UK?
The industry finds it hard to operate in the UK due to NHS cost-effectiveness assessments and pricing schemes.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Readout Loud

What is The Readout Loud about and what kind of topics does it cover?

Focused on the dynamic world of biotechnology, this podcast provides a critical examination of the latest industry news and developments. Regularly addressing significant events and trends, conversations often spotlight the implications of leadership changes, drug approvals, and pivotal public health discussions. The hosts navigate the complexities of biotech investments, regulatory hurdles, and emerging medical advancements all while emphasizing the human stories behind the innovations in the field.

Notable for its blend of industry expertise and engaging dialogue, the podcast features insights from both hosts and expert guests, effectively making complex topics accessible to a broader audience. The unique mix of scientific scrutiny and p... more

Where can I find podcast stats for The Readout Loud?

Rephonic provides a wide range of podcast stats for The Readout Loud. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Readout Loud and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Readout Loud get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Readout Loud, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Readout Loud?

Rephonic provides comprehensive predictive audience data for The Readout Loud, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Readout Loud have?

To see how many followers or subscribers The Readout Loud has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Readout Loud?

These podcasts share a similar audience with The Readout Loud:

1. BioCentury This Week
2. Biotech Hangout
3. Business Of Biotech
4. Tradeoffs
5. KFF Health News' 'What the Health?'

How many episodes of The Readout Loud are there?

The Readout Loud launched 8 years ago and published 378 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Readout Loud?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Readout Loud?

Rephonic pulls ratings and reviews for The Readout Loud from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Readout Loud?

Rephonic provides full transcripts for episodes of The Readout Loud. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Readout Loud?

Recent guests on The Readout Loud include:

1. Jared Holz
2. Dr. Dietmar Berger
3. Stacie Dusetzina
4. Matt Kapusta
5. Ari Ne'eman
6. Drew Joseph
7. Mike Rea
8. Chelsea Cirruzzo

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days